Using Biomarkers Serum Prognostic Factors for Non-Small Cell Lung Cancer: A Surgical Perspective

Ann Thorac Surg. 2018 Jul;106(1):316. doi: 10.1016/j.athoracsur.2017.11.071. Epub 2018 Jan 3.

Authors

Alessandro Baisi¹, Federico Raveglia², Alessandro Rizzi², Ugo Cioffi³

Affiliations

¹ Thoracic Surgery Unit, University of Milan, Ospedale San Paolo, Via A. di Roudinì, 8, 20142 Milan, Italy. Electronic address: alessandro.baisi@unimi.it.
² Thoracic Surgery Unit, University of Milan, Ospedale San Paolo, Via A. di Roudinì, 8, 20142 Milan, Italy.
³ Department of Surgery, University of Milan, Milan, Italy.

PMID: 29305850
DOI: 10.1016/j.athoracsur.2017.11.071

No abstract available

Publication types

Letter
Comment

MeSH terms

Biomarkers
Carcinoma, Non-Small-Cell Lung*
Humans
Lung Neoplasms*
Neoplasm Recurrence, Local
Prognosis

Substances

Biomarkers